Tecan Trading AG

Company Snapshot

Founded: 1980
Entity Type: Public
Employees: 3573
Region: Americas
Revenue: $1,196.2 Millions
Revenue Year: 2023
Headquarter: Switzerland
Key Geographics: Americas, Europe, Asia, Other Countries
Corporate Address: Seestrasse 103 8708 Männedorf Switzerland Tel: +41-44-922-8111 Web: www.tecan.com

Company Overview

Tecan Trading AG is a leading global provider of automated laboratory instruments and solutions. Its systems and components help people working in clinical diagnostics, basic and translational research and drug discovery bring their science to life. The company develops, produces and supports automated workflow solutions. Its Cavro-branded instrument components are chosen by leading instrumentation suppliers across multiple disciplines. 

Tecan works side by side with a range of clients, including diagnostic laboratories, pharmaceutical and biotechnology companies and university research centers. Its expertise extends to developing and manufacturing OEM instruments and components, marketed by its partner companies. 

Cell lines and primary cells are widely used for the production of cell-derived biomolecules, as well as for cell-based assays. Tecan provides modular automation solutions from 2D and 3D cell culture with cloning, transfection and colony picking to the point of cell-based assays and cellular analysis based on its liquid handling and detection platforms. 

Financial Highlights (FY 2023)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

Tecan Trading AG In Reports

Single-Cell Genomics and Proteomics: Emerging Technologies and Markets

BCC Research Report: Dive into Single-Cell Genomics and Proteomics Market estimates, data has been provided for 2021 and 2022 as the historic years, 2023 as the base year, and forecast for 2029.

3D Cell Cultures: Technologies and Global Markets

BCC Research Market Analyst says global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028 at a CAGR of 26.5% from 2023 through 2028.

Liquid Handling: Technologies and Global Markets

BCC Research Market Report says global liquid handling technologies market reached $4.2 billion in 2022, should reach $4.5 billion by 2023 and $6.6 billion by 2028 with a CAGR of 7.8%.

Company's Business Segments

  • Life Sciences Business (end-customer business) : This segment directly supplies end users with automated workflow solutions, such as laboratory instruments, software packages, application know-how, services, consumables, and spare parts.
  • Partnering Business (OEM business) : This segment develops and manufactures OEM instruments and components that partner companies distribute under their names.

Applications/End User Industries

  • Healthcare
  • Life Sciences